Maxwell Skor

Stock Analyst at Morgan Stanley

(0.24)
# 4,117
Out of 4,843 analysts
3
Total ratings
33.33%
Success rate
-29.84%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Maxwell Skor

TScan Therapeutics
Mar 14, 2025
Assumes: Overweight
Price Target: $10
Current: $1.44
Upside: +594.44%
Invivyd
Nov 20, 2024
Maintains: Overweight
Price Target: $9.5$3.55
Current: $0.94
Upside: +279.68%